HY-010101

N/A

Report date: 2022/03/07 17:04:36
NME

Base Information

Drug NameHY-010101
Drug Alias NameHY-010101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeriod circadian protein homolog 2 inhibitors
TargetsPeriod circadian protein homolog 2
Therapy Area/IndicationsSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Yuanji Huayi Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Yuanji Huayi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSleep Wake Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A